Ruiping Liu

Dr. Ruiping Liu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2013 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
YZY Zhang
Y Zhang
HQH Qiu
H Qiu
HZH Zhang
H Zhang
LWL Wang
L Wang
CZC Zhuang
C Zhuang
RLRuiping Liu
Ruiping Liu
Objectives: Vascular endothelial growth factor A (VEGFA) is the most potent proangiogenic molecule promoting the angiogenic phenotype of rheumatoid arthritis (RA). We hypothesized that VEGFA polymorphisms may contribute to RA susceptibility. Method: We studied VEGFA rs699947 C/A, rs2010963 G/C, and rs3025039 C/T gene polymorphisms in 329 patients with RA and 697 controls in a Chinese population. Genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Results: VEGFA rs699947 C/A, rs2010963 G/C, and rs3025039 C/T polymorphisms were not associated with the risk of RA. However, in the dominant genetic model, a significantly decreased risk for RA associated with the VEGFA rs699947 CA/AA genotypes was evident among older patients and anti-cyclic citrullinated peptide antibody (ACPA)-negative patients compared with the VEGFA rs699947 CC genotype. A significantly decreased risk for RA associated with the VEGFA rs699947 CA genotype was evident among older patients. Conclusions: These findings suggest that the functional single nucleotide polymorphism (SNP) VEGFA rs699947 C/A allele may decrease the risk of RA in older patients and ACPA-negative patients. However, our results were obtained from a moderate-sized sample and therefore this is a preliminary conclusion. Validation by a larger study from a more diverse ethnic population is needed to confirm these findings.

1 July 2015 in Gene
Verified
Journal Article
Closed access
LSLi Shen
Li Shen
HZHui Zhang
Hui Zhang
TYTing Yan
Ting Yan
GZGuoxin Zhou
Guoxin Zhou
RLRuiping Liu
Ruiping Liu

1 May 2015 in Joint Bone Spine
Verified
Journal Article
Closed access
XZXindie Zhou
Xindie Zhou
JZJinlong Zhu
Jinlong Zhu
HZHui Zhang
Hui Zhang
GZGuoxin Zhou
Guoxin Zhou
YHYong Huang
Yong Huang
RLRuiping Liu
Ruiping Liu

1 May 2015 in Gene
Verified
Journal Article
Closed access
XZXindie Zhou
Xindie Zhou
MYMumingjiang Yishake
Mumingjiang Yishake
JLJin Li
Jin Li
LJLifeng Jiang
Lifeng Jiang
LWLidong Wu
Lidong Wu
NXNanwei Xu
Nanwei Xu

27 March 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
HZHui Zhang
Hui Zhang
JPJian Pu
Jian Pu
XWXinxiang Wang
Xinxiang Wang
LSLi Shen
Li Shen
GZGongyin Zhao
Gongyin Zhao
RLRuiping Liu
Ruiping Liu

15 April 2012 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JCJinluo Cheng
Jinluo Cheng
HZHui Zhang
Hui Zhang
CZChao Zhuang
Chao Zhuang
RLRuiping Liu
Ruiping Liu
Objective.: Peptidylarginine deiminase type 4 (PADI4) and methyl-CpG binding domain 4 (MBD4) are closely related with rheumatoid arthritis (RA). We hypothesized that PADI4 and MBD4 polymorphisms may contribute to RA susceptibility.Methods.: We studied PADI4 rs2240340 G/A, PADI4 rs874881 C/G, MBD4 rs140693 G/A, and MBD4 rs2005618 T/C gene polymorphisms in 329 patients with RA and 697 controls in a Chinese population. Genotyping was done using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).Results.: When the PADI4 rs2240340 GG homozygote genotype was used as the reference group, the AA genotype was associated with a significantly increased risk of RA. In the recessive model, when PADI4 rs2240340 GG/GA genotypes were used as the reference group, the AA homozygote genotype was associated with a significant increased susceptibility to RA. PADI4 rs874881 C/G was in complete linkage disequilibrium with PADI4 rs2240340 G/A. MBD4 rs140693 G/A and MBD4 rs2005618 T/C polymorphisms were not associated with the risk of RA. In stratification analyses, a significantly increased risk for RA associated with the PADI4 rs2240340 AA genotype was evident among older patients and patients who were anticitrullinated protein antibody (ACPA)-positive compared with the PADI4 rs2240340 GG/GA genotype.Conclusion.: These findings suggest that the functional single-nucleotide polymorphism PADI4 rs2240340 G/A variant allele is associated with RA development, especially among older patients and ACPA-positive patients. However, our results were obtained from a moderate-sized sample, and therefore this is a preliminary conclusion. Validation by a larger study from a more diverse ethnic population is needed to confirm these findings.